FDA moves toward easing restrictions on certain peptides BioPharma Dive Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law Orthopedic Use of BPC 157 Sports Med Review The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA to weigh easing limits on unproven peptides favored by RFK Jr. and other MAHA figures Pittsburgh Post Gazette The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York